Future Medicine  Co., Ltd. Logo

Future Medicine Co., Ltd.

Clinical-stage biopharma developing novel synthetic drugs for inflammation, fibrosis, and oncology.

341170 | KO

Overview

Corporate Details

ISIN(s):
KR7341170009
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 창업로 54 619호, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Future Medicine Co., Ltd. is a clinical-stage biopharmaceutical company focused on the development of novel synthetic drugs. The company utilizes its proprietary FOCUSTM (Futuremedicine Origin Compound Universal System) platform, a technology based on nucleoside chemistry, to discover and regulate various in vivo targets. Its therapeutic pipeline addresses unmet medical needs in areas such as inflammation and fibrosis, including treatments for diabetic nephropathy and primary biliary cholangitis (PBC), as well as oncology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-23 00:00
Regulatory News Service
기업설명회(IR)개최결과
Korean 6.6 KB
2025-06-17 00:00
Regulatory News Service
본점소재지변경
Korean 5.1 KB
2025-06-09 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 20.7 KB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.9 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 16.0 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 333.9 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 164.6 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.8 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 5.1 KB
2024-12-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-12-06 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 22.8 KB
2024-11-29 00:00
Regulatory News Service
기업설명회(IR)개최결과
Korean 6.6 KB
2024-11-21 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2024-07-19 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 23.0 KB

Automate Your Workflow. Get a real-time feed of all Future Medicine Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Future Medicine Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Future Medicine Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.